ÌáÆð¡°SCIÂÛÎÄ¡±£¬ÈËÃǵĵÚÒ»·´Ó¦´ó¶àÊÇ¡°Ñ§ÊõÌ컨°å¡±¡£¶ø½üÈÕ£¬j9¡¤¾ÅÓλáÓÎÏ·Öйú¹Ù·½ÍøÕ¾-ÕæÈËÓÎÏ·ºÏӪƷÅÆPMLSÈ«ÇòÁÙ´²Ñ§Ô·×éÖ¯µÄÒ»Ïî¹ú¼Ê¶àÖÐÐÄÇ°Õ°ÐÔÑо¿½á¹û¾Í·¢±íÔÚÁËÓ°ÏìÒò×Ó£¨Impact Factor£©¸ß´ï10.318µÄÖØÖ¢¼à»¤Ò½Ñ§¶¥¼¶ÆÚ¿¯ <Annals of Intensive Care> ÖС£
´Ë´ÎÑо¿ÓÉÖÐÃÀ·¨Èý¹úµÄËļÒÒ½Ôº¹²Í¬²ÎÓë¡£·¨¹úÃɱËÀû°£Ê¥°£ÂåÒÁ´óѧ¡¢ÃÀ¹ú¹þ·ðҽѧԺ±´Ë¹ÒÔÉ«ÁÐŮִÊÂÒ½ÁÆÖÐÐÄ¡¢ÖйúºÓÄÏÊ¡ÈËÃñÒ½Ôº¡¢ÖйúÉϺ£½»Í¨´óѧҽѧԺ¸½ÊôÈʼÃÒ½ÔºµÄÖØÖ¢ºÍÂé×íÖªÃûר¼ÒѧÕßÇ¿Ç¿ÁªÊÖ£¬j9¡¤¾ÅÓλáÓÎÏ·Öйú¹Ù·½ÍøÕ¾-ÕæÈËÓÎÏ·ºÏӪƷÅÆÒ½ÁÆÉúÃüÐÅÏ¢ÓëÖ§³ÖÈ«ÇòÊг¡×ܼàÅ£Ð㻨ŮʿÉî¶È²ÎÓëÆäÖС£¿ç¹úµÄ¶àÖÐÐÄÏîÄ¿¼ÈΪÍâ¹úѧÕßÌṩÁËÓÅÐãµÄÖйúÁÙ´²Êµ¼ù¾Ñ飬ÓÖ°ïÖúÖйúѧÕߺÍѧÊõ¹Ûµã¸üºÃµØ×ßÏòÊÀ½ç¡£
Samir Jaber ½ÌÊÚ
Õý½ÌÊÚ
Ê¥°£ÂåÒÁ´óѧҽԺ
·¨¹úÃɱËÀû°£´óѧ
Intensive Care Medicine ¸ß¼¶¸±Ö÷±à
Daniel Talmor ½ÌÊÚ
°®µÂ»ª¡¤ÂåÎÂ˹̹½ÌÊÚ
±´Ë¹ÒÔÉ«ÁÐŮִÊÂÒ½ÁÆÖÐÐÄ
ÃÀ¹ú¹þ·ðҽѧԺ
ÕżÒÇ¿ Ö÷ÈÎ
ҽѧ²©Ê¿£¬Ö÷ÈÎҽʦ£¬½ÌÊÚ£¬²©Ê¿Ñо¿Éúµ¼Ê¦
ºÓÄÏÊ¡ÈËÃñÒ½ÔºÂé×íÓëΧÊõÆÚҽѧ¿ÆÖ÷ÈÎ
ÖйúҽʦлáÂé×íѧ·Ö»á³£ÎñίԱ
ÖлªÒ½Ñ§»áÂé×íѧ·Ö»áÈ«¹úίԱ
ÓáÎÀ·æ Ö÷ÈÎ
ҽѧ²©Ê¿£¬Ö÷ÈÎҽʦ£¬½ÌÊÚ£¬²©Ê¿Ñо¿Éúµ¼Ê¦
ÉϺ£½»Í¨´óѧҽѧԺ¸½ÊôÈʼÃÒ½ÔºÂé×í¿ÆÖ÷ÈÎ
ÉϺ£½»Í¨´óѧҽѧԺÂé×íÓëΣÖز¡Ò½Ñ§ÏµÖ÷ÈÎ
ÖйúҽʦлáÂé×íѧҽʦ·Ö»áµÚËĽìίԱ»á»á³¤
ÖлªÒ½Ñ§»áÂé×íѧ·Ö»á¸±Ö÷ÈÎίԱ
ÖлªÒ½Ñ§»áÂé×íѧ·Ö»á¶ù¿Æѧ×é×鳤
Å£Ð㻨
j9¡¤¾ÅÓλáÓÎÏ·Öйú¹Ù·½ÍøÕ¾-ÕæÈËÓÎÏ·ºÏӪƷÅÆÒ½ÁÆÉúÃüÐÅÏ¢ÓëÖ§³ÖÈ«ÇòÊг¡×ܼà
MBA
Âé×íҽʦ
Ñо¿Î§ÈÆ¡°¸ßÁ÷Á¿¸øÑõÁªºÏÃæÕÖÓ¦ÓÃÒÔ¸ÄÉÆÑõºÏÇé¿ö¡±Õ¹¿ª£¬Í¨¹ý¶Ô±È¡°ÔÚÊÖÊõÊÒʹÓøßÁ÷Á¿¸øÑõ£¨HFNO£©½øÐÐÖÏÏ¢ÑõºÏ²¢ÁªºÏÃæÕÖ½øÐÐÔ¤³äÑõ¡±ºÍ¡°³£¹æʹÓõĵ¥¶ÀÃæÕÖÔ¤³äÑõ¡±£¬·¢ÏÖÔÚÊÖÊõÊÒÖÐʹÓÃÃæÕÖÁª HFNO ½øÐÐÔ¤³äÑõºÍÖÏÏ¢ÑõºÏ£¬Óë²å¹Üºó 2 ·ÖÖÓÄÚ×îµÍºôÆøÄ©Ñõ£¨EtO2£©Ë®Æ½ÌáÉý£¬¼°¼õÉÙÑõ±¥ºÍ¶È½µµÍʼþÏà¹Ø¡£ÕâÖÖЧӦ¶Ô·ÊÅÖ»¼ÕßͬÑùÆð×÷Óá£ÕâÒ»½áÂÛÓпÉÄܸıäÁÙ´²Êµ¼ù£¬³ÉΪδÀ´ICU»òÂé×íÖÐÆø¹Ü²å¹ÜʱµÄÒ»ÏßÑ¡Ôñ¡£
ͬʱ£¬¸ÃÑо¿³É¹ûÒ²½«Ó¦ÓÃÔÚj9¡¤¾ÅÓλáÓÎÏ·Öйú¹Ù·½ÍøÕ¾-ÕæÈËÓÎÏ·ºÏӪƷÅÆAϵÁÐÂé×í»úÉÏ£¬½øÒ»²½±£ÕÏΧÂé×íÆڵIJ¡ÈË°²È«¡£
Ñо¿±³¾°
´ó¶àÊýÈ«ÉíÂé×íµÄÍâ¿ÆÊÖÊõ¶¼ÐèÒªÓд´»úеͨÆø£¬Õâ¾ÍÒªÇó½øÐÐÆø¹Ü²å¹Ü¡£È»¶ø£¬Æø¹Ü²å¹Ü¼ÈÊdz£¹æÓÖÊǸßΣ²Ù×÷£¬¿ÉÄܳöÏÖÑÏÖصĵÍÑõѪ֢£¬²¢µ¼ÖÂÐÄÔàÖèÍ£¡¢ÄÔȱÑõºÍËÀÍö¡£
Ä¿Ç°³£ÓõÄÓ¦¶Ô·½·¨ÊÇÔÚ²å¹ÜÇ°ÓÃÃæÕÖ½øÐÐÔ¤³äÑõ£¬ÒÔÔöÇ¿ÑõÆø´¢±¸²¢ÑÓ»ºµÍÑõѪ֢¡£ÓÈÆäÊǶÔÓÚÈç·ÊÅÖÈËÊ¿µÈÆøµÀ¹ÜÀíÄѶȽϴóµÄ»¼ÕßÀ´Ëµ£¬ÔÚÈ«ÂéÓÕµ¼¹ý³ÌÖУ¬Í¨¹ýÔ¤³äÑõ½øÐÐ×î´óÏ޶ȸøÑõÊDZ£ÕÏ»¼Õß°²È«µÄÖØÒªÊֶΡ£
¸ßÁ÷Á¿¸øÑõ£¨HFNO£©¼È×÷ΪһÖÖÔ¤³äÑõµÄ·½·¨£¬Ò²×÷ΪһÖÖÖÏÏ¢ÐÔÎüÑõµÄ·½·¨£¬Òѱ»¹ã·ºÓ¦ÓÃÊÖÊõÊÒ¡£µ«È±·¦¸ßÁ÷Á¿¸øÑõÁªºÏÃæÕÖÓ¦ÓÃÊÇ·ñ±È³£¹æ²Ù×÷¸üÓŵÄÁÙ´²Ö¤¾Ý¡£±¾Ñо¿¼ÙÉèHFNOÁªºÏÃæÕÖ¿ÉÒÔ¸ÄÉÆÑõºÏÇé¿ö£¬²¢ÓúôÄ©Ñõ×÷ΪÆÀ¼ÛÖ¸±ê¡£
Ñо¿Í»ÆÆ
ÔÚÒ»Ïî¹ú¼ÊÇ°Õ°ÐÔÇ°ºó¶àÖÐÐÄÑо¿ÖУ¬ÎÒÃÇÄÉÈëÁË 2022Äê9ÔÂÖÁ2022Äê12Ô£¬À´×Ô²¨Ê¿¶Ù£¨ÃÀ¹ú£©¡¢Ö£ÖÝ£¨Öйú£©¡¢ÉϺ££¨Öйú£©ºÍÃɱËÀû°££¨·¨¹ú£©ËĸöÁÙ´²¶àÖÐÐĹ²450ÃûÔÚÊÖÊõÊÒ²å¹ÜµÄ³ÉÄ껼Õß¡£²»½öÑù±¾Á¿´ó£¬»¹ÄÉÈëÁË»¼Õ߸öÈËÉíÌåÖ¸±ê¡¢ÃÀ¹úÂé×íѧ»á£¨ASA£©ÆÀ·Ö¡¢MallampatiÆÀ·Ö£¬ÒÔ¼°Âé×íºÍÊÖÊõÌصãµÈ¶à¸öÓ°ÏìÒòËØ¡£
Ç°ÆÚ½öʹÓÃÃæÕÖ½øÐÐÔ¤³äÑõ£¬ÔÚºí¾µ¼ì²éʱȡÏÂÃæÕÖ¡£ºóÆÚ²ÉÓÃÃæÕÖÁªºÏHFNOÔ¤³äÑõ£¬HFNOÓÃÓÚºí¾µ²Ù×÷ÆÚ¼äÖÏÏ¢ÑõºÏ¡£ÔÚÕû¸ö²å¹Ü¹ý³ÌÖÐά³Ö HFNO¡£Ö÷Òª½á¹ûÊDzå¹Üºó 2 ·ÖÖÓÄÚµÄ×îµÍ EtO2¡£´ÎÒª½á¹ûÊDzå¹Üºó 2 ·ÖÖÓÄÚ SpO2 ¡Ü 95%¡£¶Ô·Ç·ÊÅֺͷÊÅÖ»¼Õß½øÐÐÁËÑÇ×é·ÖÎö¡£
ÔÚ±¾´ÎÑо¿ÆÀ¹ÀµÄ 450 ´Î²å¹ÜÖУ¬ 233 ´Î½öʹÓÃÃæÕÖ£¬217 ´ÎʹÓÃÃæÕÖÁªºÏ HFNO¡£ÔÚËùÓл¼ÕßÖУ¬ÓÃÃæÕÖ²å¹Üºó 2 ·ÖÖÓÄÚµÄ×îµÍ EtO2 ÏÔÖøµÍÓÚÃæÕÖÁªºÏ HFNO£¬·Ö±ðΪ 89£¨85 - 92£©% ºÍ 91£¨88 - 93£©%£¨Æ½¾ù²î -2.20£¨ -3.21 ÖÁ -1.18)£¬p < 0.001£©¡£ÔÚ·ÊÅÖ»¼ÕßÖУ¬Ò²·¢ÏÖÁËÏàËƵĽá¹û [ 87£¨82 - 91£©% vs 90£¨88 - 92£©%£¬p = 0.004 ]£»ÓëûÓзÊÅֵĻ¼ÕßÒ»Ñù [ 90£¨86 - 92£©% vs 91£¨89 - 93£©%, p = 0.001£©]¡£µÍѪÑõʼþ£¨SpO2 ¡Ü 95%£©£¬ÃæÕÖµ¥¶ÀʹÓÃʱ£¨14/232£¬6%£©ÓëÃæÕÖÁªºÏʹÓà HFNO Ïà±È¸ü³£¼û£¨2/215£¬1%£¬p = 0.004£©¡£
´´ÐÂÕ¹Íû
½áÂÛ±íÃ÷£¬½«ÃæÕÖÓë HFNO Ïà½áºÏ½øÐÐÔ¤ÑõºÏºÍÖÏÏ¢ÑõºÏ£¬Óë²å¹Üºó 2 ·ÖÖÓÄÚ×îµÍ EtO2 ˮƽÌáÉý£¬¼°¼õÉÙÑõ±¥ºÍ¶È½µµÍʼþÏà¹Ø¡£ÕâÖÖЧӦ¶Ô·ÊÅÖ»¼ÕßͬÑùÆð×÷Óá£ÃæÕÖÁªºÏ¸ßÁ÷Á¿¸øÑõÔÚδÀ´ÓпÉÄܸıäÁÙ´²Êµ¼ù£¬×÷ΪÆø¹Ü²å¹ÜʱµÄÒ»ÏßÑ¡Ôñ¡£
µã»÷Á´½Ó£¬ÔĶÁÂÛÎÄÔÎÄ£º
Preoxygenation with standard facemask combining apnoeic oxygenation using high flow nasal cannula versuss standard facemask alone in patients with and without obesity: the OPTIMASK international studyÒýÓÃ×ÊÁÏ£º
- Jaber, S., De Jong, A., Schaefer, M.S. et al. Preoxygenation with standard facemask combining apnoeic oxygenation using high flow nasal cannula versuss standard facemask alone in patients with and without obesity: the OPTIMASK international study. Ann. Intensive Care 13, 26 (2023).
- Joffe AM, Aziz MF, Posner KL, Duggan LV, Mincer SL, Domino KB. Management of difficult tracheal intubation: a closed claims analysis. Anesthesiology. 2019;131(4):818-29.
- Patel A, Nouraei SA. Transnasal humidified rapid-insufflation ventilatory exchange (THRIVE): a physiological method of increasing apnoea time in patients with difficult airways. Anaesthesia. 2015;70(3):323-9.
- Merry AF, van Waart H, Allen SJ, Baker PA, Cumin D, Frampton CMA, et al. Ease and comfort of pre-oxygenation with high-flow nasal oxygen cannulae vs. facemask: a randomised controlled trial. Anaesthesia. 2022;77(12):1346-55.
- Mir F, Patel A, Iqbal R, Cecconi M, Nouraei SA. A randomised controlled trial comparing transnasal humidified rapid insufflation ventilatory exchange (THRIVE) pre-oxygenation with facemask pre-oxygenation in patients undergoing rapid sequence induction of anaesthesia. Anaesthesia. 2017;72(4):439-43.
- Sj?blom A, Broms J, Hedberg M, Lodenius ?, Furubacke A, Henningsson R, et al. Pre-oxygenation using high-flow nasal oxygen vs tight facemask during rapid sequence induction. Anaesthesia. 2021;76(9):1176-83.
- Bright MR, Harley WA, Velli G, Zahir SF, Eley V. High-flow nasal cannula for Apneic oxygenation in obese patients for elective surgery: a systematic review and meta-analysis. Anesth Analg. 2022.
- Vourc'h M, Baud G, Feuillet F, Blanchard C, Mirallie E, Guitton C, et al. High-flow nasal cannulae versus non-invasive ventilation for preoxygenation of obese patients: The PREOPTIPOP randomized trial. EClinicalMedicine. 2019;13:112-9.